Cargando…
MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma
Cholangiocarcinoma (CCA) is a devastating disease due to no effective treatments available. Since the non-mineral functions of vitamin D emerges, 1α,25(OH)(2)D(3), the active form of vitamin D, has been applied in anti-cancer researches. In this study, we demonstrated that both the 1α,25(OH)(2)D(3)...
Autores principales: | Chiang, Kun-Chun, Yeh, Ta-Sen, Huang, Cheng-Cheng, Chang, Yu-Chan, Juang, Horng-Heng, Cheng, Chi-Tung, Pang, Jong-Hwei S., Hsu, Jun-Te, Takano, Masashi, Chen, Tai C., Kittaka, Atsushi, Hsiao, Michael, Yeh, Chun-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335655/ https://www.ncbi.nlm.nih.gov/pubmed/28256614 http://dx.doi.org/10.1038/srep43773 |
Ejemplares similares
-
25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016) -
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016) -
MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells
por: Yang, Shih-Wei, et al.
Publicado: (2016) -
Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2013) -
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential
por: Chiang, Kun-Chun, et al.
Publicado: (2016)